Tipping the balance of benefits and harms to favor screening mammography starting at age 40 years: a comparative modeling study of risk
about
Risk factors for breast cancer for women aged 40 to 49 years: a systematic review and meta-analysisBenefits, harms, and costs for breast cancer screening after US implementation of digital mammography.Pursuing optimal thresholds to recommend breast biopsy by quantifying the value of tomosynthesis.Benefits and harms of computed tomography lung cancer screening strategies: a comparative modeling study for the U.S. Preventive Services Task ForceAssociation between computed tissue density asymmetry in bilateral mammograms and near-term breast cancer riskAggregate cost of mammography screening in the United States: comparison of current practice and advocated guidelines.Elevation of circulating branched-chain amino acids is an early event in human pancreatic adenocarcinoma development.Recommendations for breast cancer surveillance for female survivors of childhood, adolescent, and young adult cancer given chest radiation: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group.Effects of screening and systemic adjuvant therapy on ER-specific US breast cancer mortality.Mammography in asymptomatic women aged 40-49 years.Benefits, harms, and cost-effectiveness of supplemental ultrasonography screening for women with dense breasts.Targeted screening of individuals at high risk for pancreatic cancer: results of a simulation modelChanges in breast cancer risk distribution among Vermont women using screening mammographyTransition from film to digital mammography: impact for breast cancer screening through the national breast and cervical cancer early detection program.Impact of an educational intervention on provider knowledge, attitudes, and comfort level regarding counseling women ages 40-49 about breast cancer screeningBreast Tumor Prognostic Characteristics and Biennial vs Annual Mammography, Age, and Menopausal Status.Communication about colorectal cancer screening in Britain: public preferences for an expert recommendation.Diagnostic imaging and biopsy pathways following abnormal screen-film and digital screening mammography.Outcomes of screening mammography by frequency, breast density, and postmenopausal hormone therapyBenign breast disease, mammographic breast density, and the risk of breast cancer.The Role of Intraoperative Pathologic Assessment in the Surgical Management of Ductal Carcinoma In Situ.Towards personalized screening: Cumulative risk of breast cancer screening outcomes in women with and without a first-degree relative with a history of breast cancer.Collaborative Modeling of the Benefits and Harms Associated With Different U.S. Breast Cancer Screening Strategies.Prediction of near-term breast cancer risk based on bilateral mammographic feature asymmetry.Tailoring Breast Cancer Screening Intervals by Breast Density and Risk for Women Aged 50 Years or Older: Collaborative Modeling of Screening Outcomes.Population-Based Precision Cancer Screening: A Symposium on Evidence, Epidemiology, and Next Steps.Cost-effectiveness and harm-benefit analyses of risk-based screening strategies for breast cancer.Re-examining current breast cancer screening: An analysis of the 2009 U.S. Preventive Services Task Force guidelines for breast cancer screening.A systematic review and checklist presenting the main challenges for health economic modeling in personalized medicine: towards implementing patient-level models.Fifty years of age-based screening: time for a new risk-based screening approach.Risk-based Breast Cancer Screening: Implications of Breast Density.A trend analysis of breast cancer incidence rates in the United States from 2000 to 2009 shows a recent increase.A qualitative study on Singaporean women's views towards breast cancer screening and Single Nucleotide Polymorphisms (SNPs) gene testing to guide personalised screening strategies.The ANDROMEDA prospective cohort study: predictive value of combined criteria to tailor breast cancer screening and new opportunities from circulating markers: study protocol.Assessment of global and local region-based bilateral mammographic feature asymmetry to predict short-term breast cancer risk.Using Collaborative Simulation Modeling to Develop a Web-Based Tool to Support Policy-Level Decision Making About Breast Cancer Screening Initiation Age.Effectiveness of population-based service screening with mammography for women ages 40 to 49 years with a high or low risk of breast cancer: socioeconomic status, parity, and age at birth of first child.Development of a Breast Cancer Risk Prediction Model for Women in Nigeria.Simulating the Impact of Risk-Based Screening and Treatment on Breast Cancer Outcomes with MISCAN-Fadia.The Dana-Farber CISNET Model for Breast Cancer Screening Strategies: An Update.
P2860
Q24628928-30204516-B325-4B35-A9B4-20BD79F3D994Q33792616-23FDA287-B705-440A-AF87-13FBCCDE64AFQ33958483-0EE3CD11-FAE5-4722-B906-CA38014D7586Q33978331-1BFE1B29-3A2E-4D3E-818B-AFC05E64BF31Q34053289-38F3D452-2A33-41E7-A24C-247A970B5AD6Q34079901-9A7299C8-3B13-452B-95E1-BD6F3F847AF7Q34315320-F19AE8DF-2DA5-4051-8E75-BF19512C4565Q34639851-D274B526-D189-4E08-A93E-AFCD083C88CAQ34736052-DFFB5272-DA83-4AC8-818D-BAB618E577D3Q34851778-E212083E-2837-416E-A3D0-1B9A2D5648F4Q35039764-BF13108F-984F-4B33-9960-8D09D8FAD400Q35214109-5BB53BF5-1FDA-498C-899A-051395A69E16Q35221291-2C0C4E02-9F69-46E2-9F49-79F4295F3EA1Q35516764-59CAB8FC-2584-432F-81B6-889BD0A2D42AQ35592328-274CF933-30AB-412B-A063-BA0A39CB8894Q36277707-A4CE9DD6-649D-41DC-ABE5-1C34494D7338Q36451775-481B6EC0-6966-4B57-9849-1EE17928C23EQ36806768-76B1F251-0757-4A5D-9CF7-FAE85E404367Q36976948-00FA115C-F3AE-4D47-B405-F643FC2377AAQ37021220-CC2D5AD9-1F19-4DC2-9E77-5AAD687FBEC6Q37153116-CD9C25D1-400F-4F19-98AC-813C254682D6Q37172721-F27DBB77-9C5B-4635-8315-32358BE7F183Q37364628-FEDE37A3-EC28-4F03-A575-D30CE3A6F200Q37375608-7D2F7B74-C952-4A1F-935C-B033D8969C30Q37444608-87A35855-7436-4CF2-9B1C-BFD2A9E6EAD9Q37513339-286ADCF9-03C3-4E39-A696-ACB6CF55483EQ37548461-0C9BAD2B-901D-451E-B7CE-6015AC665126Q38585293-5CD56E9E-8971-48C6-8E97-953925136DB4Q39039319-7C40ADC4-32EF-41F5-8CEC-B56810C73A02Q39200598-7F8CDC0B-0D85-4940-890D-666BAB16327CQ39347821-85B12521-01BB-4C75-9E58-19061CF11CA6Q43581625-8E00015A-0620-49B6-AF44-379641FAFD8DQ46258028-208DD35B-1436-43C1-86A4-8AE5BD8EB115Q47161591-BF4C5DED-B07D-404A-9953-037C7F260670Q47262696-F8782CD5-8717-451A-8799-F7E35387AD16Q51365548-69655C1E-AC02-451A-8D1A-CD8BF5440799Q51788704-ABFA6843-E3C0-4C90-A3C4-6F90A3D52471Q52573455-C3D7374F-9813-4E0F-BC0D-DD2A38288D63Q52648599-7CC4E8D0-8974-4CDE-A417-8FAF160FC01AQ52648600-E24B0495-564F-4C2B-9ABD-9E723976D455
P2860
Tipping the balance of benefits and harms to favor screening mammography starting at age 40 years: a comparative modeling study of risk
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Tipping the balance of benefit ...... arative modeling study of risk
@ast
Tipping the balance of benefit ...... arative modeling study of risk
@en
type
label
Tipping the balance of benefit ...... arative modeling study of risk
@ast
Tipping the balance of benefit ...... arative modeling study of risk
@en
prefLabel
Tipping the balance of benefit ...... arative modeling study of risk
@ast
Tipping the balance of benefit ...... arative modeling study of risk
@en
P2093
P2860
P1476
Tipping the balance of benefit ...... arative modeling study of risk
@en
P2093
Aimee M Near
Amy Trentham-Dietz
Clyde B Schechter
Diana L Miglioretti
Diana S M Buist
Eveline A M Heijnsdijk
Harry J de Koning
Heidi D Nelson
Jeanne S Mandelblatt
P2860
P304
P356
10.7326/0003-4819-156-9-201205010-00002
P407
P577
2012-05-01T00:00:00Z